ArticleJournal of inflammation research2026
Contribution of Immune Responses to
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dengue severity is influenced by viral load and the host's immune response. Methods: This observational cross-sectional study was conducted on 62 secondary dengue patients aged 1-12 years. The ISAAC questionnaire was used to assess the history of AD. T-cell functions were evaluated by measuring the levels of IFNγ, IL10, IL13, and CCL2 cytokines in the PHA-stimulated whole blood cultures exposed to Results: The incidence of dengue hemorrhagic fever (DHF) was higher among dengue patients with AD than in those without AD (p=0.010). In the PHA-stimulated whole blood cultures exposed to SGE, higher CCL2 levels were observed in DHF patients than in dengue fever (DF) patients (p=0.044), and higher IL13 levels were found in dengue patients with AD compared to those without AD (p=0.026). In PHA-stimulated whole blood cultures without SGE, lower IFNγ levels were found in DHF patients than in DF patients (p=0.035). Conclusion: AD may be associated with a higher incidence of DHF and increased T-cell IL-13 production in response to SGE. DHF may be associated with increased T-cell CCL2 production in response to SGE, which may reflect greater cell infiltration at the bite site, and reduced T-cell IFN-γ production in response to dengue infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.